Risk Factors for Primary Cesarean Section in Egypt

July 24, 2019 updated by: Ahmed M Maged, MD, Cairo University

Evaluation of Risk Factors for Primary Cesarean Section in Egypt

women in their first pregnancy evaluated till delivery for associated risk factors for cesarean delivery

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

Evaluation of maternal , fetal, delivery place and health care provider rules to determine route of delivery in women during their first pregnancy

Study Type

Observational

Enrollment (Anticipated)

5000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Cairo, Egypt, 12151
        • Recruiting
        • Kasr Alainy Medical School

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

woman carrying their first pregnancy

Description

Inclusion Criteria:

  • women in their first pregnancy
  • Delivery between 37 and 42 weeks
  • Singleton pregnancy _ cephalic presentation

Exclusion Criteria:

  • women asked for CS on demand

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Vaginal delivery
woman who terminate their pregnancy by vaginal delivery
Procedure: vaginal delivery
pregnancy ended by vaginal delivery
Cesarean delivery
woman who terminate their pregnancy by cesarean delivery
Procedure: Cesarean section
pregnancy ended by cesarean delivery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
route of delivery in primigravida
Time Frame: at delivery
at delivery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 30, 2019

Primary Completion (Anticipated)

December 1, 2019

Study Completion (Anticipated)

January 1, 2020

Study Registration Dates

First Submitted

April 4, 2019

First Submitted That Met QC Criteria

April 4, 2019

First Posted (Actual)

April 8, 2019

Study Record Updates

Last Update Posted (Actual)

July 26, 2019

Last Update Submitted That Met QC Criteria

July 24, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 56

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cesarean Section

Clinical Trials on vaginal delivery

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe